FDA: Fluconazole linked to increased miscarriage risk

April 27, 2016

(HealthDay)—Doctors should use caution when prescribing the antifungal drug fluconazole (Diflucan) during pregnancy because it may raise the risk of miscarriage, the U.S. Food and Drug Administration warns.

The agency said it is evaluating the results of a recent Danish study that suggested a link between fluconazole and miscarriage, along with additional data, and will release final conclusions and recommendations when the review is completed.

Current labeling information suggests that a single 150 mg dose of oral fluconazole to treat is safe to take during . However, the FDA noted that in rare cases higher doses taken during pregnancy (400 to 800 mg a day) had been linked to abnormalities at birth. In the Danish study, most of the fluconazole use appeared to be one or two doses of 150 mg.

"Until the FDA's review is complete and more is understood about this study and other available data, the FDA advises cautious prescribing of oral fluconazole in pregnancy," the agency said in a news release. The agency also noted that the U.S. Centers for Disease Control and Prevention recommends only antifungal creams to treat pregnant women with vaginal yeast infections—even for longer periods than usual if the infections persist or recur.

Explore further: Use of oral antifungal medication during pregnancy, risk of spontaneous abortion

More information: More Information

Related Stories

Use of oral antifungal medication during pregnancy, risk of spontaneous abortion

January 5, 2016
In an analysis of approximately 1.4 million pregnancies in Denmark, use of the oral antifungal medication fluconazole during pregnancy was associated with an increased risk of spontaneous abortion compared with risk among ...

Anti-fungal drug not tied to most birth defects, study says

August 28, 2013
(HealthDay)—Although some reports have shown that high doses of the anti-fungal drug fluconazole (Diflucan) may raise the risk of birth defects, a new Danish review finds that more commonly prescribed lower doses of the ...

Antifungal prophylaxis regimens in liver transplant found equal

December 8, 2014
(HealthDay)—Antifungal prophylaxis is associated with reductions in invasive fungal infections (IFIs) in liver transplant recipients, according to research published in the December issue of the American Journal of Transplantation.

Medication does not lower risk of fungal infection, death among ELBW infants

May 3, 2014
Use of the antifungal medication fluconazole for six weeks for extremely low birth-weight infants did not significantly reduce the risk of death or invasive candidiasis, a serious infection that occurs when candida (a type ...

Managing migraine during pregnancy and lactation

March 30, 2016
According to doctors at Wake Forest Baptist Medical Center, medications and treatments long considered safe to treat pregnant women with migraines may not be.

New skin cancer drug approved by FDA

July 25, 2015
(HealthDay)—A new drug to treat the most common form of skin cancer has been approved by the U.S. Food and Drug Administration.

Recommended for you

Mouse model aids study of immunomodulation

November 19, 2018
Because mice do not respond to immunomodulatory drugs (IMiDs), preclinical therapeutic and safety studies of the effects of IMiDs have not been possible in existing types of mice. This has led to an inability to accurately ...

Rapid response inpatient education boosts use of needed blood-thinning drugs

November 16, 2018
A new study designed to reach hospitalized patients at risk shows that a "real-time" educational conversation, video or leaflet can lower the missed dose rates of drugs that can prevent potentially lethal blood clots in their ...

Drug overdose epidemic goes far beyond opioids, requires new policies

November 7, 2018
Most government-funded initiatives to address the overdose epidemic in the United States have targeted opioids specifically and have neglected other drugs that are increasingly implicated in overdoses, such as cocaine and ...

Zebrafish larvae help in search for appetite suppressants

November 2, 2018
Researchers at the University of Zurich and Harvard University have developed a new strategy in the search for psychoactive drugs. By analyzing the behavior of larval zebrafish, they can filter out substances with unwanted ...

FDA OKs powerful opioid pill as alternative to IV painkiller

November 2, 2018
U.S. regulators on Friday approved a fast-acting, super-potent opioid tablet as an alternative to IV painkillers used in hospitals.

Amphetamine-related hospitalizations surged between 2003 and 2015

November 2, 2018
An analysis conducted by Hennepin Healthcare, University of Minnesota School of Public Health and University of Michigan researchers shows amphetamine-related hospitalizations increased more than 270 percent from 2008 to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.